Daily Judi: Tuesday, August 30, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Enrico Mastroianni, Anna Birna Almarsdóttir, and Janine Marie Traulsen examine current versus next-generation patient engagement in the clinical trials process, and flaws in the guidelines. (Clinical Leader)
According to a new study, a group of scientists based at the Washington University School of Medicine in St. Louis have discovered a way to help clear out amyloid beta in the brains of mice, possibly leading to new therapeutics to combat Alzheimer’s disease. (Fierce Biotech)
Duke University School of Nursing has created a new podcast, "Breaking Research Barriers." Through the combination of storytelling and shared expertise, the show intends to focus on equity and inclusion in clinical research. (Duke University School of Nursing)
The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team Judi will be there!
We also hope to see you this September 13-14, in Boston, for DPHARM: Disruptive Innovations to Advance Clinical Trials, walking distance from our North End headquarters.
Our Culture
“Technology and process improvements will continue to decrease our timelines on creating specifications by 50 percent or more, this year. The more we continue to improve the faster we will be.”
–Jamie, Trial Delivery
About Judi
Judi is on a mission to empower the ecosystems that drive clinical trial success by improving their workflows. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.